Contact Person : Registration Team; Last Date for the submission of abstract : Not Available ; Description : An enormous amount of clinical information has been gathered regarding the use of ErbB-targeted agents in breast cancer, from metastatic disease to early-stage settings, and in numerous combinations and regimens.